在轴性脊椎关节炎中推进精准医学:从多omics方法的见解
Yuanpiao Ni1,2,3, Quanbo Zhang1,4, Xin Wu5
1Research Center of Hyperuricemia and Gout, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Frontiers in medicine
|November 26, 2025
概括
多组学和人工智能的进步为轴性脊柱关节炎 (axSpA) 病原体提供了新的见解. 这种方法有望改善axSpA患者的诊断,个性化治疗和临床翻译.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 代谢学 代谢学 代谢学
- 精准医学是一门精准的医学.
背景情况:
- 轴性脊柱关节炎 (axSpA) 是一种慢性炎症状况,具有复杂的病因因素,包括遗传,免疫,代谢和环境影响.
- 这种疾病显著影响患者的生活质量,需要先进的理解和治疗策略.
研究的目的:
- 审查多omics技术的应用,以解开axSpA.的病变发生.
- 探索多omics数据在识别 axSpA. 新生物标志物和治疗点的潜力.
- 在 axSpA.中讨论人工智能 (AI) 在整合和分析精密医学的多学科数据中的作用.
主要方法:
- 在axSpA研究中对多种omics (基因组学,转录组学,蛋白质组学,代谢组学) 应用的当前文献的综述.
- 分析这些技术如何有助于了解疾病机制,遗传易感性,免疫反应和代谢变化.
- 检查AI在数据集成,分析和构建动态疾病网络中的作用.
主要成果:
- 多omics技术为axSpA病变发生提供了前所未有的洞察力,揭示了关键的遗传,免疫和代谢途径.
- 这些方法已经确定了潜在的生物标志物和治疗点,为精准医学铺平了道路.
- 人工智能集成提高了多omics数据分析的精度,并促进了动态疾病模型的开发.
结论:
- 结合人工智能的多态学具有显著的潜力,可以彻底改变axSpA的诊断和个性化治疗.
- 这种综合方法可以加速临床转化,并推进慢性炎症疾病的精准医学领域.
- 解决数据集成方面的挑战对于充分实现axSpA管理中的多主题和人工智能的好处至关重要.
相关概念视频
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
Genomics
39.6K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K


